Cortechs secures €1.3 million for cutting-edge ADHD technology

EU Horizon2020 funding will help commercialise innovative ADHD treatment: CereBrill – Clinical investigations to follow in University College, Cork. Cortechs is looking to expand its team in Dublin, Galway and Cork over two years. The company is raising a further €500,000 to ramp up operations and deliver CereBrill solution throughout Europe and North America.

CortechsConnecthas been awarded significant EU funding to speed the scale of its CereBrill enterprise solution (brain training tools to improve the focus of children with ADHD) faster in the enormous €393 billion cognitive impairment market CereBrill is Cortechs’ novel treatment for ADHD whereby children learn to improve their attention levels through reward-based computer games.

The €1.3 million Horizon 2020 funding is the third time Cortechs has secured funds from the European Commission for its ADHD solutions, with the company’s founder Dr Áine Behan planning to use the money – and further private investment – to expand the company’s team in Dublin, Galway and Cork.

Dr. Áine Behan, CEO and founder of award-winning Irish business Cortechs: “We are delighted to have secured significant funding like this, given how competitive the call is and how few European companies are successful in this SME Instrument. This means we can fill highly skilled positions in our Dublin and Galway company bases straight away.

“Getting products like CereBrill to market could have a hugely positive societal impact and significantly cut treatment costs in children with ADHD,” continued Dr Behan. “Digital solutions for behavioural difficulties in conditions like this hold huge power to reduce behavioural interventions, reduce clinical visits and free up clinician schedules.”

“We are actively talking to investors now and, with commitments already made to invest, we want to close private funding in the coming months so we can leverage this EU funding to get our CereBrill product into the healthcare market as soon as possible,” added Dr Behan. “This is a very exciting time for Cortechs and we can’t wait to move forward with our enterprise solution.”

Cortechs creates data-driven, therapeutic games that use cognitive training and brainwaves to improve attention levels in children with Attention Deficit Hyperactivity Disorder (ADHD). The games use fun tasks to improve attention deficit; brainwaves can be remotely assessed by specialist clinicians to prescribe game tasks via secure web dashboards to parents and children.

CereBrill is an enterprise solution that takes key evidence-based ADHD treatments and applies them to an end-to-end digital solution to improve attention deficit in ADHD. The solution can be used on any platform or smartphone and can be remotely and securely controlled and moderated by specialist ADHD clinicians.

The €1.3 million in funding is part of the European Innovation Council (EIC) pilot that supports top-class innovators, entrepreneurs, small companies and scientists with funding opportunities and business acceleration services. Cortechs was one of the 3% of applicants from all over Europe to secure funding through this
instrument in 2018. Current investors in Cortechs include investors like Aviva & Holtzbrinck Publishers (Founders Factory UK), National Digital Research Centre, Startplanet and Enterprise Ireland.

Cortechs is the leading commercial partner in a Horizon2020 project called FocusLocus (www.focuslocus.eu) where active pilots of its ADHD gaming technology (created with Greek academic and Spanish clinical and commercial partners) is already underway within Sant Joan de Deu Barcelona Childrens Hospital since September 2018.